Companies/Phibro Animal Health Corporation

Company profile

Phibro Animal Health Corporation

NASDAQ: PAHC · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ Teaneck, NJCIK 0001069899Reports USD

#134 of 1,394 Healthcare companies by revenue71st-percentile growth

EA Score

75B+

FH 78DQ 72GM 72SS 76

v0.1 · 65/100 weight · provisional

↑ return on equity, filing timeliness · ↓ balance-sheet leverage, disclosure history

Methodology →

Revenue TTM

$1.5B

Rev growth YoY (TTM)

+26.0%

Net income (FY)

$48.3M

Employees

1,940

Market cap

$1.3B

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$1.3B$1.3B2025

Net income$48.3M$48.3M2025

Operating income$110.5M$110.5M2025

Total assets$1.4B$1.4B2025

Liabilities$1.1B$1.1B2025

Equity$285.7M$285.7M2025

Revenue trend

FY2019 – FY2025 · USD

$820.0M

FY19

$828.0M

FY19

$800.4M

FY22

$833.4M

FY22

$942.3M

FY22

$977.9M

FY23

$1.0B

FY24

$1.3B

FY25

Revenue by segment

Filed disclosures · FY2025

By product

Vaccines100%

By geography

UNITED STATES57%

Latin America and Canada23%

EMEA12%

Asia Pacific8%

The read

Phibro Animal Health Corporation booked $1.3B in FY2025 revenue, growing 27% year over year — faster than most Healthcare companies we track, at a 3.7% net margin.

Peers · Healthcare

AMN Healthcare Services, Inc.70B Inspire Medical Systems, Inc.78B+The Pennant Group, Inc.73B Omada Health62C

Key facts

CEOJack Clifford Bendheim

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersTeaneck, NJ

ExchangeNASDAQ: PAHC

Employees1,940

IPO date2014-04-11

Latest filings

8-K2026-06-26 10-Q2026-05-06 8-K2026-05-06 8-K2026-05-05 8-K2026-04-30 8-K2026-04-27 8-K2026-04-14 8-K2026-02-04

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.